Annual Current Assets
$111.11 M
-$19.34 M-14.82%
31 December 2023
Summary:
Y-mAbs Therapeutics annual total current assets is currently $111.11 million, with the most recent change of -$19.34 million (-14.82%) on 31 December 2023. During the last 3 years, it has fallen by -$11.25 million (-9.20%). YMAB annual current assets is now -47.58% below its all-time high of $211.96 million, reached on 31 December 2019.YMAB Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$99.06 M
-$27.71 M-21.86%
30 September 2024
Summary:
Y-mAbs Therapeutics quarterly total current assets is currently $99.06 million, with the most recent change of -$27.71 million (-21.86%) on 30 September 2024. Over the past year, it has dropped by -$15.80 million (-13.76%). YMAB quarterly current assets is now -62.48% below its all-time high of $264.01 million, reached on 31 March 2021.YMAB Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMAB Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -14.8% | -13.8% |
3 y3 years | -9.2% | -57.0% |
5 y5 years | -26.7% | -0.5% |
YMAB Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -45.1% | at low | -57.0% | at low |
5 y | 5 years | -47.6% | at low | -62.5% | at low |
alltime | all time | -47.6% | +543.7% | -62.5% | +38.1% |
Y-mAbs Therapeutics Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $99.06 M(-21.9%) |
June 2024 | - | $126.76 M(+17.1%) |
Mar 2024 | - | $108.27 M(-2.6%) |
Dec 2023 | $16.76 M(+52.2%) | $111.11 M(-3.3%) |
Sept 2023 | - | $114.86 M(-0.8%) |
June 2023 | - | $115.78 M(-6.6%) |
Mar 2023 | - | $124.01 M(-4.9%) |
Dec 2022 | $11.01 M(+4.6%) | $130.45 M(-2.1%) |
Sept 2022 | - | $133.24 M(-13.4%) |
June 2022 | - | $153.92 M(-13.4%) |
Mar 2022 | - | $177.74 M(-12.1%) |
Dec 2021 | $10.52 M | $202.26 M(-12.3%) |
Sept 2021 | - | $230.58 M(-7.5%) |
June 2021 | - | $249.37 M(-5.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $264.01 M(+115.8%) |
Dec 2020 | $9.68 M(+119.5%) | $122.36 M(-8.1%) |
Sept 2020 | - | $133.21 M(-18.4%) |
June 2020 | - | $163.32 M(-14.0%) |
Mar 2020 | - | $189.84 M(-10.4%) |
Dec 2019 | $4.41 M(+1025.3%) | $211.96 M(+112.8%) |
Sept 2019 | - | $99.59 M(-19.2%) |
June 2019 | - | $123.19 M(-10.1%) |
Mar 2019 | - | $137.03 M(-9.6%) |
Dec 2018 | $392.00 K(-49.2%) | $151.53 M(-8.7%) |
Sept 2018 | - | $166.04 M(+131.5%) |
June 2018 | - | $71.73 M(-21.5%) |
Dec 2017 | $772.00 K(>+9900.0%) | $91.36 M |
Dec 2016 | $0.00 | - |
FAQ
- What is Y-mAbs Therapeutics annual total current assets?
- What is the all time high annual current assets for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual current assets year-on-year change?
- What is Y-mAbs Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly current assets year-on-year change?
What is Y-mAbs Therapeutics annual total current assets?
The current annual current assets of YMAB is $111.11 M
What is the all time high annual current assets for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual total current assets is $211.96 M
What is Y-mAbs Therapeutics annual current assets year-on-year change?
Over the past year, YMAB annual total current assets has changed by -$19.34 M (-14.82%)
What is Y-mAbs Therapeutics quarterly total current assets?
The current quarterly current assets of YMAB is $99.06 M
What is the all time high quarterly current assets for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly total current assets is $264.01 M
What is Y-mAbs Therapeutics quarterly current assets year-on-year change?
Over the past year, YMAB quarterly total current assets has changed by -$15.80 M (-13.76%)